Evidence map›Paper›PMID 38412264›Full record

ArticleACS chemical biology2024

Exponential Combination of

Miao Yu, T M Simon Tang, Lila Ghamsari, Graham Yuen, Claudio Scuoppo, Jim A Rotolo, Barry J Kappel, Jody M Mason

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Molecular medicine reports · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Miao YuDepartment of Life Sciences, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom.
T M Simon TangDepartment of Life Sciences, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom.
Lila GhamsariSapience Therapeutics, Inc. 500 Mamaroneck Ave. Suite 320, Tarrytown, New York 10591, United States.
Graham YuenSapience Therapeutics, Inc. 500 Mamaroneck Ave. Suite 320, Tarrytown, New York 10591, United States.
Claudio ScuoppoSapience Therapeutics, Inc. 500 Mamaroneck Ave. Suite 320, Tarrytown, New York 10591, United States.
Jim A RotoloSapience Therapeutics, Inc. 500 Mamaroneck Ave. Suite 320, Tarrytown, New York 10591, United States.
Barry J KappelSapience Therapeutics, Inc. 500 Mamaroneck Ave. Suite 320, Tarrytown, New York 10591, United States.
Jody M MasonDepartment of Life Sciences, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom.ORCID 0000-0002-4118-1958
University of Bath · GB

Funding

Medical Research Council MR/T028254/1
6 · The paper itself

Abstract

Activating transcription factor 3 (ATF3) is an activation transcription factor/cyclic adenosine monophosphate (cAMP) responsive element-binding (CREB) protein family member. It is recognized as an important regulator of cancer progression by repressing expression of key inflammatory factors such as interferon-γ and chemokine (C-C motif) ligand 4 (CCL4). Here, we describe a novel library screening approach that probes individual leucine zipper components before combining them to search exponentially larger sequence spaces not normally accessible to intracellular screening. To do so, we employ two individual semirational library design approaches and screen using a protein-fragment complementation assay (PCA). First, a 248,832-member library explored 12 amino acid positions at all five

Indexed as

Activating Transcription Factor 3Peptide LibraryCyclic AMP Response Element-Binding ProteinGene Expression RegulationPeptidesActivating Transcription Factor 3Cyclic AMP Response Element-Binding ProteinPeptide LibraryPeptides

Identifiers

PMID38412264
PMCPMC10949195
OpenAlexW4392188134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.